LifeScan is post-effective and in wind-down: substantially all assets were transferred to LFSN Bidco LLC when the plan became effective on December 8, 2025, while claims reconciliation and remaining plan administration continue and a final-decree application is anticipated by December 31, 2026, according to the latest LifeScan Global post-confirmation reportDkt. 760.
The company and its affiliates filed chapter 11 on July 15, 2025 after a sustained shift from blood glucose monitoring to continuous glucose monitoring compressed their core market, burdensome pharmacy-benefit-manager and Medicaid rebate arrangements left the U.S. business with less than 9% of wholesale acquisition cost and an approximately 3% EBITDA margin on gross sales, and delays in a planned continuous-glucose-monitoring launch left the debtors unable to address approaching maturities. They had also missed the September 2024 maturity payment on approximately $27.4 million of third-lien debt. At filing, LifeScan reported approximately $364.7 million of first-lien term loans, $275 million of second-lien term loans, the third-lien debt, and roughly $1.03 billion of outstanding rebate claims. The first-day declarationDkt. 20 described a revised restructuring support agreement backed by approximately 97% of secured creditors and Platinum Equity, targeting the elimination of about $1.4 billion of liabilities through a plan coupled with a dual-track section 363 market test.
That process ultimately produced a credit-bid sale rather than a standalone reorganization of the legacy debtors. On the effective date, secured creditor classes received plan distributions, existing equity was cancelled, and a $60 million GUC trust was funded for allowed general unsecured claims; the reorganized debtors retain no interest in the trust, and final recoveries remain dependent on claims reconciliation. LifeScan Global reported approximately $522 million of cumulative secured-claim distributions through June 30, 2026 in its post-confirmation reportDkt. 760. The immediate docket milestone is August 22, 2026, the response deadline on the GUC trustee’s notice of scheduled claims superseded by filed proofs of claimDkt. 765; absent a timely response, the identified scheduled claims will be disregarded in favor of the corresponding filed claims. The case is therefore on a claims-administration and closure path, with the operating assets already separated from the estate and the remaining work centered on reconciling claims, administering the GUC trust, and obtaining final decrees.
